Virus injection targets Hard-to-Treat cancers in early trial
NCT ID NCT05938296
First seen Nov 19, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This early-stage trial tests a new treatment called BS006, a virus designed to infect and destroy cancer cells. It is given as an injection directly into tumors in people with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, find the best dose, and see if the virus can shrink tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center
Detroit, Michigan, 48201, United States
-
Orlando Health Cancer Institute
Orlando, Florida, 32806, United States
Conditions
Explore the condition pages connected to this study.